525 related articles for article (PubMed ID: 14677675)
1. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
[TBL] [Abstract][Full Text] [Related]
2. Regulation of conditionally licensed biologicals in the United States.
Hill RE
Dev Biol (Basel); 2004; 117():147-52. PubMed ID: 15597632
[TBL] [Abstract][Full Text] [Related]
3. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
[TBL] [Abstract][Full Text] [Related]
4. Licensing veterinary biologics in the United States.
Espeseth DA
Dev Biol Stand; 1992; 79():17-25. PubMed ID: 1286752
[TBL] [Abstract][Full Text] [Related]
5. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
Gay CG
Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
[TBL] [Abstract][Full Text] [Related]
6. Translating research into licensed vaccines and validated and licensed diagnostic tests.
Hill RE; Foley PL; Clough NE; Ludemann LR; Murtle DC
Dev Biol (Basel); 2013; 135():53-8. PubMed ID: 23689883
[TBL] [Abstract][Full Text] [Related]
7. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s.
Espeseth DA; Lasher H
Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169
[TBL] [Abstract][Full Text] [Related]
8. Canadian regulatory requirements for recombinant fish vaccines.
Sethi MS; Gifford GA; Samagh BS
Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
[TBL] [Abstract][Full Text] [Related]
9. Regulation of veterinary biological products for fish in the United States.
Birnbaum NG
Dev Biol Stand; 1997; 90():335-40. PubMed ID: 9270861
[TBL] [Abstract][Full Text] [Related]
10. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
Foley PL; Hill RE
Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
[TBL] [Abstract][Full Text] [Related]
11. Regulation of autogenous biologicals in the United States.
Schmellik-Sandage CS; Hill RE
Dev Biol (Basel); 2004; 117():9-13. PubMed ID: 15597610
[TBL] [Abstract][Full Text] [Related]
12. USDA licensing policy for biologicals produced by R-DNA.
Espeseth DA; Shibley GP; Joseph PL; van Deusen RA; Whetstone CA
Dev Biol Stand; 1985; 59():167-73. PubMed ID: 4007275
[TBL] [Abstract][Full Text] [Related]
13. Regulatory requirements for vaccine authorisation.
Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
[TBL] [Abstract][Full Text] [Related]
14. The American manufacturer's view on the EEC texts and harmonization.
Draayer HA; Hilsabeck LJ; Miller RH
Dev Biol Stand; 1992; 79():77-83. PubMed ID: 1286768
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
16. Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority.
Hill RE
Procedia Vaccinol; 2011; 5():141-145. PubMed ID: 32288916
[TBL] [Abstract][Full Text] [Related]
17. The Unites States Department of Agriculture Regulation of Veterinary Biological Products. The use of prelicensing evaluation and postlicensing monitoring to achieve regulatory compliance.
Hill RE; Randall DC
Qual Assur; 1995 Dec; 4(4):323-8. PubMed ID: 8890360
[TBL] [Abstract][Full Text] [Related]
18. Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe.
Saegerman C; Hubaux M; Urbain B; Lengelé L; Berkvens D
Rev Sci Tech; 2007 Aug; 26(2):395-413. PubMed ID: 17892160
[TBL] [Abstract][Full Text] [Related]
19. Comparison of requirements in the European Union and United States of America for pre-clinical viral safety testing of veterinary vaccines.
Sheridan S; Coughlin J
Biologicals; 2010 May; 38(3):340-5. PubMed ID: 20400329
[TBL] [Abstract][Full Text] [Related]
20. Development and approval of vaccines in the United States.
Botstein P
Isr J Med Sci; 1986; 22(3-4):268-71. PubMed ID: 3528047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
